Media
Media content pertaining to the business and technologies of Deep Genomics
Press Releases Media Events

Understanding AI Foundation Models: What every pharmaceutical company needs to know
June 18, 2024

Healthcare Business Today
Read More

Pioneering the Largest Foundation Model to Transform RNA Research: An Interview with Brendan Frey
June 13, 2024

BioPharmaTrend 
Read More

Deep Genomics, now flush with cash, plans to take dozens of RNA therapies to the clinic
July 30, 2021

Endpoints News
Read More

Toronto AI meets Boston biotech: Deep Genomics raises $180 million to automate drug discovery
July 28, 2021

The Boston Globe
Read More

DEEP GENOMICS SECURES $226 MILLION CAD LED BY SOFTBANK AS IT SCALES AI DRUG DISCOVERY PLATFORM
July 28, 2021

BetaKit
Read More

Deep Genomics hits the partnering ground running with BioMarin deal
November 18, 2020

Amirah Al Idrus, Fierce Biotech

Read More

BioMarin taps AI upstart Deep Genomics for discovery pact; Praxis says it has a path to lifting clinical hold
November 17, 2020

Jason Mast, Amber Tong, Endpoints News

Read More

Deep Genomics nabs a CBO from Synlogic as it looks to ramp up partnering
November 5, 2020

Amirah Al Idrus, Fierce Biotech

Read More

Find Us

Corporate Headquarters: 480 University Avenue, Suite 1300 Toronto, Ontario, Canada, M5G 1V2
Boston Office: 1 Canal Park, Suite 100 Cambridge, MA 02141, USA

Follow Us

Contact Us

For PR enquiries:
press@deepgenomics.com
© 2025 DEEP GENOMICS. ALL RIGHTS RESERVED. PRIVACY POLICY